In our study, SFRP2 promoter methylation in tumor area was positively correlated with insulin and HOMA-IR in tumor tissue from > 30th CRC patients, but also SFRP2 methylation in tumor-free area was correlated with HOMA-IR. This evidence concerns the gene SFRP2 and colorectal carcinoma.